Filing Details
- Accession Number:
- 0001618835-20-000248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 17:22:52
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2020-11-18 17:22:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1618835 | Evofem Biosciences Inc. | EVFM | Pharmaceutical Preparations (2834) | 208527075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726277 | J. Justin File | C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-17 | 7,760 | $2.17 | 258,168 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
